Herold KC - Search Results

1

TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.

Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC. Bisikirska B, et al. Among authors: herold kc. J Clin Invest. 2005 Oct;115(10):2904-13. doi: 10.1172/JCI23961. Epub 2005 Sep 15. J Clin Invest. 2005. PMID: 16167085 Free PMC article.

2

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.

Herold KC, Bluestone JA, Montag AG, Parihar A, Wiegner A, Gress RE, Hirsch R. Herold KC, et al. Diabetes. 1992 Mar;41(3):385-91. doi: 10.2337/diab.41.3.385. Diabetes. 1992. PMID: 1532369

3

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA. Lenschow DJ, et al. Among authors: herold kc. J Exp Med. 1995 Mar 1;181(3):1145-55. doi: 10.1084/jem.181.3.1145. J Exp Med. 1995. PMID: 7532678 Free PMC article.

4

Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model.

Alegre ML, Sattar HA, Herold KC, Smith J, Tepper MA, Bluestone JA. Alegre ML, et al. Among authors: herold kc. Transplantation. 1994 Jun 27;57(12):1786-94. Transplantation. 1994. PMID: 8016885

5

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, Fuchs E, Singh B, Thompson CB, Bluestone JA. Lenschow DJ, et al. Among authors: herold kc. Immunity. 1996 Sep;5(3):285-93. doi: 10.1016/s1074-7613(00)80323-4. Immunity. 1996. PMID: 8808683 Free article.

6

CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin.

Herold KC, Vezys V, Koons A, Lenschow D, Thompson C, Bluestone JA. Herold KC, et al. J Immunol. 1997 Jan 15;158(2):984-91. J Immunol. 1997. PMID: 8993020

7

Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation.

Herold KC, Lu J, Rulifson I, Vezys V, Taub D, Grusby MJ, Bluestone JA. Herold KC, et al. J Immunol. 1997 Nov 1;159(9):4150-3. J Immunol. 1997. PMID: 9379007

8

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA. Herold KC, et al. N Engl J Med. 2002 May 30;346(22):1692-8. doi: 10.1056/NEJMoa012864. N Engl J Med. 2002. PMID: 12037148 Free article. Clinical Trial.

9

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

Herold KC, Burton JB, Francois F, Poumian-Ruiz E, Glandt M, Bluestone JA. Herold KC, et al. J Clin Invest. 2003 Feb;111(3):409-18. doi: 10.1172/JCI16090. J Clin Invest. 2003. PMID: 12569167 Free PMC article.

10

Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?

Herold KC, Taylor L. Herold KC, et al. Immunol Res. 2003;28(2):141-50. doi: 10.1385/IR:28:2:141. Immunol Res. 2003. PMID: 14610290 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters